161 related articles for article (PubMed ID: 11002220)
1. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.
Peracaula R; Cleary KR; Lorenzo J; de Llorens R; Frazier ML
Cancer; 2000 Sep; 89(6):1252-8. PubMed ID: 11002220
[TBL] [Abstract][Full Text] [Related]
2. The expression of the carboxyl ester lipase gene in pancreas and pancreatic adenocarcinomas.
Reuss R; Aberle S; Klingel K; Sauter M; Greschniok A; Franke FE; Padberg W; Blin N
Int J Oncol; 2006 Sep; 29(3):649-54. PubMed ID: 16865281
[TBL] [Abstract][Full Text] [Related]
3. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor.
Ito T; Ito M; Shiozawa J; Naito S; Kanematsu T; Sekine I
Mod Pathol; 1999 Jul; 12(7):669-74. PubMed ID: 10430270
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states.
Peracaula R; Royle L; Tabares G; Mallorqui-Fernández G; Barrabés S; Harvey DJ; Dwek RA; Rudd PM; de Llorens R
Glycobiology; 2003 Apr; 13(4):227-44. PubMed ID: 12626415
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma.
Moskovitz AH; Linford NJ; Brentnall TA; Bronner MP; Storer BE; Potter JD; Bell RH; Rabinovitch PS
Genes Chromosomes Cancer; 2003 Jun; 37(2):201-6. PubMed ID: 12696069
[TBL] [Abstract][Full Text] [Related]
6. Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.
Uhland K; Siphos B; Arkona C; Schuster M; Petri B; Steinmetzer P; Mueller F; Schweinitz A; Steinmetzer T; Van De Locht A
Int J Oncol; 2009 Aug; 35(2):347-57. PubMed ID: 19578749
[TBL] [Abstract][Full Text] [Related]
7. Heparanase expression in primary and metastatic pancreatic cancer.
Koliopanos A; Friess H; Kleeff J; Shi X; Liao Q; Pecker I; Vlodavsky I; Zimmermann A; Büchler MW
Cancer Res; 2001 Jun; 61(12):4655-9. PubMed ID: 11406531
[TBL] [Abstract][Full Text] [Related]
8. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
9. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
Suehara N; Mizumoto K; Muta T; Tominaga Y; Shimura H; Kitajima S; Hamasaki N; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 1997 Jun; 3(6):993-8. PubMed ID: 9815776
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.
Sipos B; Hahn D; Carceller A; Piulats J; Hedderich J; Kalthoff H; Goodman SL; Kosmahl M; Klöppel G
Histopathology; 2004 Sep; 45(3):226-36. PubMed ID: 15330800
[TBL] [Abstract][Full Text] [Related]
12. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
[TBL] [Abstract][Full Text] [Related]
13. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
14. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients.
Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Ozdogan M; Suleymanlar I; Balci MK; Griffith TS; Sanlioglu S
Pancreas; 2009 Mar; 38(2):154-60. PubMed ID: 18981952
[TBL] [Abstract][Full Text] [Related]
15. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of topoisomerase IIa expression in pancreatic ductal adenocarcinoma: a pilot study using chromogenic in situ hybridization and immunohistochemistry on tissue microarrays.
Tsiambas E; Karameris A; Tiniakos DG; Karakitsos P
Pancreatology; 2007; 7(1):45-52. PubMed ID: 17449965
[TBL] [Abstract][Full Text] [Related]
17. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.
Hwang TL; Liang Y; Chien KY; Yu JS
Proteomics; 2006 Apr; 6(7):2259-72. PubMed ID: 16493704
[TBL] [Abstract][Full Text] [Related]
18. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
[TBL] [Abstract][Full Text] [Related]
19. Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.
Evans JD; Cornford PA; Dodson A; Greenhalf W; Foster CS; Neoptolemos JP
Pancreatology; 2001; 1(3):254-62. PubMed ID: 12120204
[TBL] [Abstract][Full Text] [Related]
20. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.
Juuti A; Lundin J; Nordling S; Louhimo J; Haglund C
Oncology; 2006; 71(1-2):61-8. PubMed ID: 17377415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]